Check out this great video
How Qilaser Works
The Qilaser treatment activates dormant stem cells within your own blood, activating autologous, pluripotent stem cells from your own body, an exact DNA match, with no risk of rejection or negative side effects. Using a photo-acoustic light signal to active stem cells and other powerful growth factors from the platelet in your blood and encourages Vsels to express protein molecules which allow the cells to adhere to the location and also facilitate communication with neighboring cells, which informs the function, protein expression and even the epigenetic of damaged or dysfunctional cells. Once activated the Qilaser is used to guide the activated stem cells to whatever parts of the body is most needed to repair and rejuvenate. Due to the fact that these cells had been dormant and not dividing, the telomere length are considered to be of embryonic age. The spore like nature of the dormant cells protect them from aging.
Once your stem cells are activated by the Qilaser photo acoustic device and infused into your body, they are guided by cytokine pathways to areas needing regeneration and rejuvenation. Therefor this procedure is activating and reinfusing youthful pluripotent stem cells that contain your own DNA that has not experienced the wear and tear of aging. Once they are lead to the correct destination within your body they both adhere and begin rebuilding and communicate and influence neighboring cells in a positive way.
1. The first step is to tune the laser to the desired stem cell application.
2. The second step is to treat the stem cells with the QiLaser so that the stem cells are activated outside the body. This allows them to be more easily directed for their intended purpose.
3. In the third step the QiLaser is used to guide the stem cells to a specific location in the body. The QiLaser penetrates deeply and accurately through tissue, providing a homing signature that directs the stem cells to concentrate where they are needed. The basic instruction given to the stem cells is “go there and stay there and repair there.” Once connected, cell to cell communication in tissue directs the cells to integrate in the tissue.
Qigenix (“key-gen’-ix”) is a privately held clinical stage medical device company founded by Dr. Todd Ovokaitys in Carlsbad, California. The Qigenix lead product is the QiLaser, which is designed to increase homing and integration of stem cells. The QiLaser is effective with many different types of stem cells and, as a low power laser using advanced holographic signals, it can penetrate 6-8 centimeters into the human body, providing critical messaging for stem cells destined for major organs.
The first disease within the regenerative market that Qigenix will focus on is heart failure. Nearly 6 million Americans are currently living with Congestive Heart Failure (CHF). Approximately 550,000 new cases are diagnosed in the U.S. each year.
Congestive Heart Failure affects people of all ages, from children and young adults to the middle-aged and the elderly. Almost 1.4 million persons with CHF are under 60 years of age. Heart failure is responsible for 11 million physician visits each year, and more hospitalizations than all forms of cancer combined. The first clinical study of CHF with the QiLaser is being conducted in Armenia using stem cells from cord blood infused through an IV.